Showing results (81-90 of 179) with videos related to
Sort By:
Pageof 18
Scientific Reports|July 22, 2021
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjectsCarlo De Matteis, Marica Cariello, Giusi Graziano, et al.Clinical Biochemistry|February 27, 2007
Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile saltsMichele Petruzzelli, Michele Vacca, Antonio Moschetta, et al.Journal of Lipid Research|September 8, 2007
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorptionDiana Jung, Takeshi Inagaki, Robert D Gerard, et al.Plos Biology|September 2, 2009
REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasisGwendal Le Martelot, Thierry Claudel, David Gatfield, et al.Current Drug Targets. Immune, Endocrine and Metabolic Disorders|August 11, 2005
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone diseasePiero Portincasa, Antonio Moschetta, Karel J van Erpecum, et al.Plos One|April 28, 2026
Apple-derived miR-482a-3p decreases c-MYB expression and proliferation of human intestinal cell linesEmanuela Pasculli, Marica Cariello, Maria Arconzo, et al.World Journal of Gastroenterology|December 21, 2004
Primary sclerosing cholangitis: updates in diagnosis and therapyPiero Portincasa, Michele Vacca, Antonio Moschetta, et al.Scientific Reports|March 18, 2025
Atherogenic index of plasma identifies subjects with severe liver steatosisCarlo De Matteis, Fabio Novielli, Ersilia Di Buduo, et al.Cell Cycle (Georgetown, Tex.)|August 25, 2011
Bax is necessary for PGC1α pro-apoptotic effect in colorectal cancer cellsIlenia D'Errico, Giuseppe Lo Sasso, Lorena Salvatore, et al.Cancers|July 9, 2022
Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon CancerMarica Cariello, Roberta Zerlotin, Emanuela Pasculli, et al.Pageof 18